VANDELLI, Carmen
 Distribuzione geografica
Continente #
NA - Nord America 3.063
EU - Europa 1.401
AS - Asia 970
SA - Sud America 127
AF - Africa 13
Continente sconosciuto - Info sul continente non disponibili 2
OC - Oceania 1
Totale 5.577
Nazione #
US - Stati Uniti d'America 3.037
GB - Regno Unito 360
SG - Singapore 327
PL - Polonia 314
CN - Cina 281
SE - Svezia 208
HK - Hong Kong 160
IT - Italia 139
DE - Germania 114
BR - Brasile 102
TR - Turchia 78
VN - Vietnam 74
RU - Federazione Russa 60
UA - Ucraina 59
FI - Finlandia 47
BG - Bulgaria 26
NL - Olanda 20
CA - Canada 13
FR - Francia 13
BE - Belgio 12
AR - Argentina 11
KR - Corea 10
ZA - Sudafrica 9
CZ - Repubblica Ceca 7
IE - Irlanda 7
EC - Ecuador 6
IN - India 6
MX - Messico 6
ID - Indonesia 5
BD - Bangladesh 4
CL - Cile 4
IQ - Iraq 4
JP - Giappone 4
AT - Austria 3
IL - Israele 3
LT - Lituania 3
AL - Albania 2
CO - Colombia 2
EG - Egitto 2
ES - Italia 2
EU - Europa 2
GD - Grenada 2
IR - Iran 2
MY - Malesia 2
RO - Romania 2
SA - Arabia Saudita 2
AE - Emirati Arabi Uniti 1
AU - Australia 1
AZ - Azerbaigian 1
BZ - Belize 1
CH - Svizzera 1
CR - Costa Rica 1
DO - Repubblica Dominicana 1
DZ - Algeria 1
HN - Honduras 1
JM - Giamaica 1
JO - Giordania 1
KZ - Kazakistan 1
LU - Lussemburgo 1
MA - Marocco 1
MN - Mongolia 1
PE - Perù 1
PH - Filippine 1
PT - Portogallo 1
PY - Paraguay 1
QA - Qatar 1
UZ - Uzbekistan 1
Totale 5.577
Città #
Santa Clara 315
Warsaw 312
Fairfield 284
Ashburn 254
Southend 229
Woodbridge 222
Chandler 198
Singapore 183
Houston 177
Hong Kong 160
Ann Arbor 127
Wilmington 127
Jacksonville 120
Nyköping 97
Dearborn 89
Seattle 85
Chicago 83
Cambridge 78
Los Angeles 75
London 63
Beijing 55
Hefei 50
Izmir 50
Salt Lake City 37
Moscow 32
San Diego 32
Princeton 30
New York 27
Sofia 26
Des Moines 25
Eugene 25
Ho Chi Minh City 25
Hanoi 23
Shanghai 20
Boardman 19
Helsinki 19
Munich 19
Dallas 18
Modena 17
Buffalo 16
Amsterdam 14
Tampa 14
São Paulo 12
Brussels 11
Lancaster 11
Sterling 11
The Dalles 10
Frankfurt am Main 9
Reggio Nell'emilia 9
Falls Church 8
Milan 8
Seoul 8
Dublin 7
Elk Grove Village 7
San Jose 7
Brooklyn 6
Guangzhou 6
Johannesburg 6
Redwood City 6
San Mateo 6
Bologna 5
Bremen 5
Miami 5
Phoenix 5
Xi'an 5
Auburn Hills 4
Brno 4
Denver 4
Detroit 4
Groningen 4
Jersey City 4
Kansas City 4
Kunming 4
Newark 4
Norwalk 4
Orem 4
Porto Alegre 4
Rio de Janeiro 4
Toronto 4
Turku 4
Ankara 3
Atlanta 3
Augusta 3
Brasília 3
Columbus 3
Council Bluffs 3
Da Nang 3
Goiânia 3
Grafing 3
Guayaquil 3
Hải Dương 3
Kilburn 3
Montreal 3
Olomouc 3
Ottawa 3
Philadelphia 3
Phủ Lý 3
Quito 3
Redondo Beach 3
Tokyo 3
Totale 4.164
Nome #
AISF position paper on liver transplantation and pregnancy: Women in Hepatology Group, Italian Association for the Study of the Liver (AISF) 573
Lack of evidence of sexual transmission of hepatitis C among monogamous couples: Results of a 10-year prospective follow-up study 310
Genetic polymorphisms of interleukin-6 modulates fibrosis progression in mild chronic hepatitis C. 285
The cyclophilin inhibitor Debio 025 combined with PEG IFNα2a significantly reduces viral load in treatment-naive hepatitis C patients. 271
Combined blockade of programmed death-1 and activation of CD137 increase responses of human liver T cells against HBV, but not HCV 265
Apolipoprotein E genotypes modulate fibrosis progression in patients with chronic hepatitis C and persistently normal transaminases 265
Fibrosis progression in HCV carriers with mild hepatitis who possess the high-repetition variant of the DRD4 gene, a genetic marker for binge-drinking and risk-seeking behavior: a longitudinal study 235
A survey of adverse events in 11 241 patients with chronic viral hepatitis treated with alfa interferon 230
Chronic hepatitis C and psychosocial distress 221
Demographic, etiological and clinical features of liver cirrhosis at the onset of the first episode of clinical decompensation: Preliminary results of the “A.I.S.F.-EPASCO” Study. 218
Parametri predittivi e risposta sostenuta alla terapia antivirale combinata nell'epatite cronica attivva HCV correlata (ECA HCV) 217
Efficacy and safety of increasing doses of the cyclophilin inhibitor Debio 025 in combination with pegylated Interferon alpha-2a in treatment naïve mono-infected HCV patients. 43rd Annual Meeting of the European Association for the Study of the Liver (EASL). Milano,Italia, 23-27 Aprile, 2008. 205
Mortality risk according to different clinical characteristics of first episode of liver decompensation in cirrhotic patients: a nationwide, prospective, 3-year follow-up study in Italy 201
The interleukin 28B rs12979860 C/T polymorphism and serum cholesterol as predictors of fibrosis progression in patients with chronic hepatitis C and persistently normal transaminases 184
Analysis of factors involved in fibrosis progression among hepatitis C virus carriers with normal alanine aminotransferares. 41st Annual Meeting of the European Association for the Study of the Liver (EASL).Vienna, Austria, 26-30 Aprile 2006. 178
Long-term interferon therapy in patients with refractory chronic hepatitis C: effect on histological liver damage and hepatocellular carcinogenesis. 175
Efficacy and safety of increasing doses of the cyclophilin inhibitor Debio 025 in combination with pegylated Interferon alpha-2a in treatment naïve mono-infected HCV patients. 172
Health-related quality of life in recent and long standing chronic HCV infection. 170
Demographic, etiological and clinical features of liver cirrhosis at the onset of the first episode of clinical decompensation: Preliminary results of the “A.I.S.F.-EPASCO” 170
Hepatitis C virus carriers with normal alanine aminotransferases: analysis of factors involved in fibrosis progression. 42nd Annual Meeting of the European Association for the Study of the Liver (EASL). Barcellona, Spagna, 11-15 aprile 2007. 169
Metodologia per l’adozione di linee guida cliniche in Medicina Interna. 156
Prediciting the natural history of patients with epatitis C and persistently normal transaminases: a longitudinal long term study with dual biopsies. 43rd Annual Meeting of the European Association for the Study of the Liver (EASL). 155
The virologic and histologic status in anti HCV+ve subjects with normal ALT levels: results of a ten year prospective follow-up study. 154
Demographic, etiological and clinical features of 500 consecutive patients with liver cirrhosis at the onset of the first episode of decompensation. 50th Anniversary Meeting of the International Association for the Study of Liver Diseases (AASLD). San Francisco, 31 Ottobre- 4 Novembre 2008. 154
Demographic, etiological and clinical features of 500 consecutive patients with liver cirrhosis at the onset of the first episode of decompensation. 50th Anniversary Meeting of the International Association for the Study of Liver Diseases (AASLD) 150
Prediciting the natural history of patients with epatitis C and persistently normal transaminases: a longitudinal long term study with dual biopsies. 43rd Annual Meeting of the European Association for the Study of the Liver (EASL). Milano, Italia, 23-27 Aprile, 2008. 119
Prediction of successful outcome in a randomised controlled trial of the long-term efficacy of interferon alpha treatment for chronic hepatitis C 2
Totale 5.604
Categoria #
all - tutte 21.145
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 21.145


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/2021356 0 0 0 0 0 43 90 67 21 57 43 35
2021/2022476 9 58 50 59 13 24 26 13 56 34 90 44
2022/2023526 61 68 36 46 63 92 3 52 84 2 11 8
2023/2024318 8 21 14 32 49 19 52 79 6 2 11 25
2024/20251.035 36 13 7 137 221 150 60 32 136 46 71 126
2025/20261.295 85 53 95 211 448 403 0 0 0 0 0 0
Totale 5.604